Sotirios Stergiopoulos is the Founder, President & CEO at A2A Pharmaceuticals. Previously, Sotirios was the Chief Medical Officer, SVP and Head of Global Medical Affairs at Ipsen. Sotirios holds a Masters of Biotechnology Enerprise and Entrepreneurship from Johns Hopkins University.
Sign up to view 4 direct reports
Get started